people have died after coronavirus vaccines

Mercola: Are the COVID Jabs Responsible for Rising Mortality Trends?​

by Dr. Joseph Mercola | Mercola.com
October 21st 2021, 12:03 pm

Link: https://www.infowars.com/posts/mercola-are-the-covid-jabs-responsible-for-rising-mortality-trends/


Did COVID-19 raise the death toll despite mass vaccination, or are people dying at increased rates because of it?

"Between 800,000 and 2 million so-called 'COVID19 deaths' may in fact be vaccine-induced deaths.”

STORY AT-A-GLANCE
  • According to all-cause mortality statistics adjusted for population growth, the number of Americans who have died between January 2021 and August 2021 is 14% higher than 2018, the pre-COVID year with the highest all-cause mortality, and 16% higher than the average death rate between 2015 and 2019
  • Did COVID-19 raise the death toll despite mass vaccination, or are people dying at increased rates because of it?
  • The COVID jab killed an estimated 1,018 people per million doses administered during the first 30 days of the European vaccination campaign
  • When counting only deaths categorized as COVID-19 deaths, the death toll from the jabs is estimated to be between 200 and 500 deaths per million doses administered. With 4 billion doses having been administered around the world, that means 800,000 to 2 million so-called “COVID-19 deaths” may in fact be vaccine-induced deaths
  • Data from 23 countries reveal the number of new COVID cases (i.e., positive tests) after the start of the COVID jab campaign is 3.8 times higher than it was before the rollout of the shots, and the daily COVID death rate is 3.82 times higher
According to all-cause mortality statistics,1 the number of Americans who have died between January 2021 and August 2021 is 16% higher than 2018, the pre-COVID year with the highest all-cause mortality, and 18% higher than the average death rate between 2015 and 2019. Adjusted for population growth of about 0.6% annually, the mortality rate in 2021 is 16% above the average and 14% above the 2018 rate.


The obvious question is, why did more people die in 2021 (January through August) despite the rollout of COVID shots in December 2020? Did COVID-19 raise the death toll despite mass vaccination, or are people dying at increased rates because of the COVID jabs?

Vaccine-Induced Mortality​

In a two-part series,2 Matthew Crawford of the Rounding the Earth Newsletter, examined mortality statistics before and after the rollout of the COVID shots. In Part 1,3 he revealed the shots killed an estimated 1,018 people per million doses administered (note, this is doses, not the number of individuals vaccinated) during the first 30 days of the European vaccination campaign.

“Between 800,000 and 2 million so-called ‘COVID19 deaths’ may in fact be vaccine-induced deaths.”
Click to expand...
After adjusting for deaths categorized as COVID-19 deaths, he came up with an estimate of 200 to 500 deaths per million doses administered. With 4 billion doses having been administered around the world, that means 800,000 to 2 million so-called “COVID-19 deaths” may in fact be vaccine-induced deaths. As explained by Crawford:4

“This does not even include vaccine-induced deaths that have not been recorded as COVID cases, though I suspect that latter number is smaller since the only good way to hide the vaccine mortality signal is to smuggle deaths through the already-established COVID death toll.”

Corroborating Crawford’s calculations are data from Norway, where 23 deaths were reported following the COVID jab at a time when only 40,000 Norwegians had received the shot.


Not taking into account the possibility of underreporting in Norway, that gives us a mortality rate of 575 deaths per million doses administered. What’s more, after conducting autopsies on 13 of those deaths, all 13 were determined to be linked to the COVID jab. As reported by Norway Today back in January 2021:5

“‘The reports might indicate that common side effects from mRNA vaccines, such as fever and nausea, may have led to deaths in some frail patients,’ chief physician Sigurd Hortemo in the Norwegian Medicines Agency noted.

The Norwegian Medicines Agency and the National Institute of Public Health (FHI) jointly assess all side effects reports. As a result, the FHI has updated the corona vaccination guide with new advice on the vaccination of frail elderly people.

‘If you are very frail, you should probably not be vaccinated,’ Steinar Madsen at the Norwegian Medicines Agency said at a webinar on corona vaccine for journalists …”

Is the COVID Jab Responsible for Excess Deaths?​

Crawford goes on to look at data from countries that have substantial vaccine uptake while simultaneously having very low rates of COVID-19. This way, you can get a better idea as to whether the COVID jabs might be responsible for the excess deaths, as opposed to the infection itself.

He identified 23 countries that fit this criteria, accounting for 1.88 billion individuals, roughly one-quarter of the global population. Before the COVID jabs rolled out, these nations reported a total of 103.2 COVID-related deaths per million residents. Five nations had more than 200 COVID deaths per million while seven had fewer than 10 deaths per million.

As of August 1, 2021, 25.35% of inhabitants in these 23 nations had received a COVID jab and 10.36% were considered fully vaccinated. In all, 673 million doses had been administered. Based on these data, Crawford estimates the excess death rate per million vaccine doses is 411, well within the window of the 200 to 500 range he calculated in Part 1.

Equally intriguing is the finding that the number of new COVID cases (i.e., positive tests) after the start of the COVID jab campaign is 3.8 times higher than it was before the rollout of the shots, and the daily COVID death rate is 3.82 times higher.

Morocco and Saudi Arabia were the only two nations in which the case rate and COVID death rates went down after the vaccination campaign started. “If deaths were scaled by 3.82 due to the vaccines, then there were 276,465 excess deaths during this time span,” Crawford writes.

He goes through a number of adjustments to remove outliers that might skew the data sets, so for a more detailed review, see the original article. But in summary, after removing nations with more than 100 COVID deaths per million before their vaccination program (to evaluate the impact of the shots alone), he came up with 13 countries with a combined population of 354 million.

The number of doses administered in these 13 countries is similar to the original cohort. The adjusted number of excess deaths per million is now 318, which is still within the 200 to 500 per million range.

Remarkably, though, the number of COVID deaths in these 13 countries is 11.61 times higher post-vaccination, compared to before the jabs were rolled out. In five of the 13 countries, a whopping 90% of their COVID-19 fatalities have been logged after their vaccination campaigns began! This obliterates any fantasy that the COVID injections are actually helping.

“On face, these results reinforce the case that the experimental vaccines are killing people,” Crawford writes. “At the very least, this is one more dramatic [lack of] safety signal that should spur authorities who care about our health to come to the table for a discussion about how to refine the data they’re not analyzing to anyone’s knowledge …

More concerning is that numerous of these nations — largely located in Asia — seemed to have no susceptibility at all to the pandemic prior to vaccination. There are a lot of theories as to why this might be aside from just vaccines triggering deaths.

  • Might PCR testing pick up signals from attenuated virus vaccines, resulting in case explosions (from almost none) to match the [new] deaths?
  • Could some of these vaccines have faulty production … during polio vaccine rollout? This could result in cases and deaths?
  • Paraguay has by far the greatest signal of vaccine-induced mortality. It stands out as one of the only nations on Earth to use both Chinese and also Western vaccines. Is there any reason such a combination could result in more volatile disease spread?
  • Do we really believe that the braintrust at the FDA and CDC are entirely unaware of these observations?
Meanwhile, health authorities still seem to have no issue with the lack of risk report or risk-benefit analysis performed by any of the vaccine manufacturers or anyone else. This strikes me as one of the worst signs in my lifetime that corporations have taken over government on an essentially complete level.”

US Whistleblower Highlights Underreporting​

In mid-July 2021, America’s Frontline Doctors, represented by Renz Law,6 filed a lawsuit7 against the secretary of the U.S. Department of Health and Human Services, Xavier Becerra. In that lawsuit, they cite whistleblower testimony by a computer programmer with expertise in health care data analytics and access to Medicare and Medicaid data maintained by the Centers for Medicare and Medicaid Services (CMS).

According to this whistleblower, the U.S. Vaccine Adverse Event Reporting System (VAERS) under-reports deaths caused by the COVID shots by a conservative factor of five or more. She claims the number of Americans killed by the shots was at least 45,000 as of July 9, 2021.

At that time, VAERS reported 9,048 deaths following COVID injection. That number is now 16,310 (as of October 1, 20218). Using an under-reporting factor of five, that gives us an estimated death toll of 81,550.

COVID Shots May Have Killed More Than 200,000 in the US​

Steve Kirsch, executive director of the COVID-19 Early Treatment Fund, has come up with even more drastic numbers. In the video “Vaccine Secrets: COVID Crisis,”9 he argues that VAERS can be used to determine causality, and shows how the VAERS data indicate more than 212,000 Americans have already been killed by the COVID shots.10

Anywhere from 2 million to 5 million have also been injured by them in some way. Kirsch is so confident in his analyses, he’s offered a $1 million academic grant to anyone who can show his analysis is flawed by a factor of four or more. He’s even offered $1 million to any official willing to simply have a public debate with him about the data, and none has accepted the challenge.

Woman’s Obituary Blames COVID Vaccine for Her Death​

While it may be challenging to determine exactly how many people have died as a direct result of the COVID shots, we can be certain that deaths are occurring.

One Oregon woman’s obituary11 went viral after her family blamed side effects of the COVID-19 vaccine on her death. The family minced no words, calling out state and local governments for their “heavy-handed vaccine mandates.” Jessica Berg Wilson left behind a husband and two young daughters, aged 5 and 3.

“Jessica Berg Wilson, 37, of Seattle, Washington, passed away unexpectedly September 7, 2021 from COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) surrounded by her loving family,” the obituary states.12

“Jessica was an exceptionally healthy and vibrant 37-year-old young mother with no underlying health conditions … Local and state governments were determined to strip away her right to consult her wisdom and enjoy her freedom.

She had been vehemently opposed to taking the vaccine, knowing she was in good health and of a young age and thus not at risk for serious illness. In her mind, the known and unknown risks of the unproven vaccine were more of a threat.

But, slowly, day by day, her freedom to choose was stripped away. Her passion to be actively involved in her children’s education — which included being a Room Mom — was, once again, blocked by government mandate.

Ultimately, those who closed doors and separated mothers from their children prevailed. It cost Jessica her life. It cost her children the loving embrace of their caring mother. And it cost her husband the sacred love of his devoted wife.”

COVID Jab Effects Are Rapidly Waning​

To add insult to injury, there’s ample evidence showing that whatever benefit you glean from the COVID jab is short-lived, requiring you to risk life and limb yet again with another booster shot (and probably more to come after that).

If you need a refresher on the potential mechanisms of harm, download and read Stephanie Seneff’s excellent paper,13 “Worse Than The Disease: Reviewing Some Possible Unintended Consequences of mRNA Vaccines Against COVID-19,” published in the International Journal of Vaccine Theory, Practice and Research in collaboration with Dr. Greg Nigh.

Among those incriminating data sets is an analysis by Humetrix,14 which assessed the effectiveness of mRNA COVID-19 vaccines against the delta variant among 5.6 million Medicare beneficiaries, aged 65 and older. Three key questions answered by the data analysis are:
  1. Is vaccine effectiveness waning over time?
  2. Is vaccine effectiveness reduced for the delta variant?
  3. Does the need for a booster shot vary by sub-population?
The executive summary lays out the answers:
  1. Yes, the effectiveness of both Moderna and Pfizer’s injections rapidly wane in this cohort.
  2. As of mid-August 2021, the vaccine effectiveness against delta infection was only 41% and effectiveness against hospitalization due to the delta variant was 62%, both of which are “lower than previously reported.”
  3. The shots were even less effective in those over the age of 75, and a breakthrough hospitalization risk model suggests prioritizing people over age 65 for boosters.

Breakthrough Infections Don’t Seem so Rare in the Elderly​

According to Humetrix, between January 2021 and August 14, 2021, 5.6 million Medicare beneficiaries (out of 20 million) were fully vaccinated with either two doses of Pfizer or Moderna, or one dose of Janssen.

Of those, 148,000 experienced a breakthrough infection, 30,000 required hospitalization and 9,400 needed intensive care. That means breakthrough infections in this age group occur at a rate of about 1 in 38, which doesn’t strike me as being particularly rare.

As per Centers for Disease Control and Prevention guidance, patients were only considered fully vaccinated two weeks after the second dose. So, anyone who developed COVID-19 symptoms before then were not counted.

While the analysis reports success, saying the hospitalization rate for breakthrough infections was reduced by one-third compared to the hospitalization rate between March and December 2020, and the death rate in breakthrough infections was reduced six-fold, a central problem remains.

The shots don’t protect you for very long. As shown on Page 8 of the PowerPoint, the breakthrough infection rate at five and six months’ post-vaccination is double the rate at three and four months’ post-vaccination.

Considering the risk of lethal vaccine injury is elevated in the elderly — as noted by the Norwegian Medicines Agency — starting them on a treadmill of booster shots strikes me as an idea that can only end in heartbreak for families around the world.

“The Truth About COVID-19” exposes the hidden agenda behind the pandemic, showing the countermeasures have nothing to do with public health and everything to do with ushering in a new social and economic system based on totalitarian, technocracy-led control. So, it’s not misinformation they fear. It’s the truth they want to prevent from spreading. Pick up a copy of this best-selling book today before it’s too late.

 

57 Top Scientists and Doctors Release Shocking Study on COVID Vaccines and Demand Immediate Stop to All Vaccinations​

By Dr. Roxana Bruno, Dr. Peter McCullough, and et al.
Global Research, October 30, 2021
enVolve 8 May 2021

Link: https://www.globalresearch.ca/57-to...emand-immediate-stop-all-vaccinations/5746848

covid-19-breakthrough-cases-yankees-feature-800x417-400x209.jpg

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Visit and follow us on Instagram at @crg_globalresearch.
First published on May 8, 2021
***
A group of 57 leading scientists, doctors and policy experts has released a report calling in to question the safety and efficacy of the current COVID-19 vaccines and are now calling for an immediate end to all vaccine programs. We urge you to read and share this damning report.
There are two certainties regarding the global distribution of Covid-19 vaccines. The first is that governments and the vast majority of the mainstream media are pushing with all their might to get these experimental drugs into as many people as possible. The second is that those who are willing to face the scorn that comes with asking serious questions about vaccines are critical players in our ongoing effort to spread the truth.
You can read an advanced copy of this manuscript in preprint below. It has been prepared by nearly five dozen highly respected doctors, scientists, and public policy experts from across the globe to be urgently sent to world leaders as well as all who are associated with the production and distribution of the various Covid-19 vaccines in circulation today.
There are still far too many unanswered questions regarding the Covid-19 vaccines’ safety, efficacy, and necessity. This study is a bombshell that should be heard by everyone, regardless of their views on vaccines. There aren’t nearly enough citizens who are asking questions. Most people simply follow the orders of world governments, as if they have earned our complete trust. They haven’t done so. This manuscript is a step forward in terms of accountability and the free flow of information on this crucial subject. Please take the time to read it and share it widely.
-enVolve, May 8, 2021
*
Original Source: Authorea

SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developers
Abstract
Since the start of the COVID-19 outbreak, the race for testing new platforms designed to confer immunity against SARS-CoV-2, has been rampant and unprecedented, leading to emergency authorization of various vaccines. Despite progress on early multidrug therapy for COVID-19 patients, the current mandate is to immunize the world population as quickly as possible. The lack of thorough testing in animals prior to clinical trials, and authorization based on safety data generated during trials that lasted less than 3.5 months, raise questions regarding the safety of these vaccines. The recently identified role of SARS-CoV-2 glycoprotein Spike for inducing endothelial damage characteristic of COVID-19, even in absence of infection, is extremely relevant given that most of the authorized vaccines induce the production of Spike glycoprotein in the recipients. Given the high rate of occurrence of adverse effects, and the wide range of types of adverse effects that have been reported to date, as well as the potential for vaccine-driven disease enhancement, Th2-immunopathology, autoimmunity, and immune evasion, there is a need for a better understanding of the benefits and risks of mass vaccination, particularly in the groups that were excluded in the clinical trials. Despite calls for caution, the risks of SARS-CoV-2 vaccination have been minimized or ignored by health organizations and government authorities. We appeal to the need for a pluralistic dialogue in the context of health policies, emphasizing critical questions that require urgent answers if we wish to avoid a global erosion of public confidence in science and public health.
Introduction
Since COVID-19 was declared a pandemic in March 2020, over 150 million cases and 3 million deaths have been reported worldwide. Despite progress on early ambulatory, multidrug-therapy for high-risk patients, resulting in 85% reductions in COVID-19 hospitalization and death [1], the current paradigm for control is mass-vaccination. While we recognize the effort involved in development, production and emergency authorization of SARS-CoV-2 vaccines, we are concerned that risks have been minimized or ignored by health organizations and government authorities, despite calls for caution [2-8].
Vaccines for other coronaviruses have never been approved for humans, and data generated in the development of coronavirus vaccines designed to elicit neutralizing antibodies show that they may worsen COVID-19 disease via antibody-dependent enhancement (ADE) and Th2 immunopathology, regardless of the vaccine platform and delivery method [9-11]. Vaccine-driven disease enhancement in animals vaccinated against SARS-CoV and MERS-CoV is known to occur following viral challenge, and has been attributed to immune complexes and Fc-mediated viral capture by macrophages, which augment T-cell activation and inflammation [11-13].
In March 2020, vaccine immunologists and coronavirus experts assessed SARS-CoV-2 vaccine risks based on SARS-CoV-vaccine trials in animal models. The expert group concluded that ADE and immunopathology were a real concern, but stated that their risk was insufficient to delay clinical trials, although continued monitoring would be necessary [14]. While there is no clear evidence of the occurrence of ADE and vaccine-related immunopathology in volunteers immunized with SARS-CoV-2 vaccines [15], safety trials to date have not specifically addressed these serious adverse effects (SAE). Given that the follow-up of volunteers did not exceed 2-3.5 months after the second dose [16-19], it is unlikely such SAE would have been observed. Despite92 errors in reporting, it cannot be ignored that even accounting for the number of vaccines administered, according to the US Vaccine Adverse Effect Reporting System (VAERS), the number of deaths per million vaccine doses administered has increased more than 10-fold. We believe there is an urgent need for open scientific dialogue on vaccine safety in the context of large-scale immunization. In this paper, we describe some of the risks of mass vaccination in the context of phase 3 trial exclusion criteria and discuss the SAE reported in national and regional adverse effect registration systems. We highlight unanswered questions and draw attention to the need for a more cautious approach to mass vaccination.
SARS-CoV-2 phase 3 trial exclusion criteria
With few exceptions, SARS-CoV-2 vaccine trials excluded the elderly [16-19], making it impossible to identify the occurrence of post-vaccination eosinophilia and enhanced inflammation in elderly people. Studies of SARS-CoV vaccines showed that immunized elderly mice were at particularly high risk of life-threatening Th2 immunopathology [9,20]. Despite this evidence and the extremely limited data on safety and efficacy of SARS-CoV-2 vaccines in the elderly, mass-vaccination campaigns have focused on this age group from the start. Most trials also excluded pregnant and lactating volunteers, as well as those with chronic and serious conditions such as tuberculosis, hepatitis C, autoimmunity, coagulopathies, cancer, and immune suppression [16-29], although these recipients are now being offered the vaccine under the premise of safety.
Another criterion for exclusion from nearly all trials was prior exposure to SARS-CoV-2. This is unfortunate as it denied the opportunity of obtaining extremely relevant information concerning post-vaccination ADE in people that already have anti-SARS-Cov-2 antibodies. To the best of our knowledge, ADE is not being monitored systematically for any age or medical condition group currently being administered the vaccine. Moreover, despite a substantial proportion of the population already having antibodies [21], tests to determine SARS-CoV-2-antibody status prior to administration of the vaccine are not conducted routinely.
Will serious adverse effects from the SARS-CoV-2 vaccines go unnoticed?
COVID-19 encompasses a wide clinical spectrum, ranging from very mild to severe pulmonary pathology and fatal multi-organ disease with inflammatory, cardiovascular, and blood coagulation dysregulation [22-24]. In this sense, cases of vaccine-related ADE or immunopathology would be clinically-indistinguishable from severe COVID-19 [25]. Furthermore, even in the absence of SARS-CoV-2 virus, Spike glycoprotein alone causes endothelial damage and hypertension in vitro and in vivo in Syrian hamsters by down-regulating angiotensin-converting enzyme 2 (ACE2) and impairing mitochondrial function [26]. Although these findings need to be confirmed in humans, the implications of this finding are staggering, as all vaccines authorized for emergency use are based on the delivery or induction of Spike glycoprotein synthesis. In the case of mRNA vaccines and adenovirus-vectorized vaccines, not a single study has examined the duration of Spike production in humans following vaccination. Under the cautionary principle, it is parsimonious to consider vaccine-induced Spike synthesis could cause clinical signs of severe COVID-19, and erroneously be counted as new cases of SARS-CoV-2 infections. If so, the true adverse effects of the current global vaccination strategy may never be recognized unless studies specifically examine this question. There is already non-causal evidence of temporary or sustained increases138 in COVID-19 deaths following vaccination in some countries (Fig. 1) and in light of Spike’s pathogenicity, these deaths must be studied in depth to determine whether they are related to vaccination.
Unanticipated adverse reactions to SARS-CoV-2 vaccines
Another critical issue to consider given the global scale of SARS-CoV-2 vaccination is autoimmunity. SARS-CoV-2 has numerous immunogenic proteins, and all but one of its immunogenic epitopes have similarities to human proteins [27]. These may act as a source of antigens, leading to autoimmunity [28]. While it is true that the same effects could be observed during natural infection with SARS-CoV-2, vaccination is intended for most of the world population, while it is estimated that only 10% of the world population has been infected by SARS-CoV-2, according to Dr. Michael Ryan, head of emergencies at the World Health Organization. We have been unable to find evidence that any of the currently authorized vaccines screened and excluded homologous immunogenic epitopes to avoid potential autoimmunity due to pathogenic priming.
WHO: No Guarantee COVID Vaccines Will Prevent People from Being Infected
Some adverse reactions, including blood-clotting disorders, have already been reported in healthy and young vaccinated people. These cases led to the suspension or cancellation of the use of adenoviral vectorized ChAdOx1-nCov-19 and Janssen vaccinesin some countries. It has now been proposed that vaccination with ChAdOx1-nCov-19 can result in immune thrombotic thrombocytopenia (VITT) mediated by platelet-activating antibodies against Platelet factor-4, which clinically mimics autoimmune heparin-induced thrombocytopenia [29]. Unfortunately, the risk was overlooked when authorizing these vaccines, although adenovirus-induced thrombocytopenia has been known for more than a decade, and has been a consistent event with adenoviral vectors [30]. The risk of VITT would presumably be higher in those already at risk of blood clots, including women who use oral contraceptives [31], making it imperative for clinicians to advise their patients accordingly.
At the population level, there could also be vaccine-related impacts. SARS-CoV-2 is a fast-evolving RNA virus that has so far produced more than 40,000 variants [32,33] some of which affect the antigenic domain of Spike glycoprotein [34,35]. Given the high mutation rates, vaccine-induced synthesis of high levels of anti-SARS-CoV-2-Spike antibodies could theoretically lead to suboptimal responses against subsequent infections by other variants in vaccinated individuals [36], a phenomenon known as “original antigenic sin” [37] or antigenic priming [38]. It is unknown to what extent mutations that affect SARS-CoV-2 antigenicity will become fixed during viral evolution [39], but vaccines could plausibly act as selective forces driving variants with higher infectivity or transmissibility. Considering the high similarity between known SARS-CoV-2 variants, this scenario is unlikely [32,34] but if future variants were to differ more in key epitopes, the global vaccination strategy might have helped shape an even more dangerous virus. This risk has recently been brought to the attention of the WHO as an open letter [40].
Discussion
The risks outlined here are a major obstacle to continuing global SARS-CoV-2 vaccination. Evidence on the safety of all SARS-CoV-2 vaccines is needed before exposing more people to the184 risk of these experiments, since releasing a candidate vaccine without time to fully understand the resulting impact on health could lead to an exacerbation of the current global crisis [41]. Risk-stratification of vaccine recipients is essential. According to the UK government, people below 60 years of age have an extremely low risk of dying from COVID-191 187 . However, according to Eudravigillance, most of the serious adverse effects following SARS-CoV-2 vaccination occur in people aged 18-64. Of particular concern is the planned vaccination schedule for children aged 6 years and older in the United States and the UK. Dr. Anthony Fauci recently anticipated that teenagers across the country will be vaccinated in the autumn and younger children in early 2022, and the UK is awaiting trial results to commence vaccination of 11 million children under 18. There is a lack of scientific justification for subjecting healthy children to experimental vaccines, given that the Centers for Disease Control and Prevention estimates that they have a 99.997% survival rate if infected with SARS-CoV-2. Not only is COVID-19 irrelevant as a threat to this age group, but there is no reliable evidence to support vaccine efficacy or effectiveness in this population or to rule out harmful side effects of these experimental vaccines. In this sense, when physicians advise patients on the elective administration of COVID-19 vaccination, there is a great need to better understand the benefits and risk of administration, particularly in understudied groups.
In conclusion, in the context of the rushed emergency-use-authorization of SARS-CoV-2 vaccines, and the current gaps in our understanding of their safety, the following questions must be raised:
  • Is it known whether cross-reactive antibodies from previous coronavirus infections or vaccine206 induced antibodies may influence the risk of unintended pathogenesis following vaccination with COVID-19?
  • Has the specific risk of ADE, immunopathology, autoimmunity, and serious adverse reactions been clearly disclosed to vaccine recipients to meet the medical ethics standard of patient understanding for informed consent? If not, what are the reasons, and how could it be implemented?
  • What is the rationale for administering the vaccine to every individual when the risk of dying from COVID-19 is not equal across age groups and clinical conditions and when the phase 3 trials excluded the elderly, children and frequent specific conditions?
  • What are the legal rights of patients if they are harmed by a SARS-CoV-2 vaccine? Who will cover the costs of medical treatment? If claims were to be settled with public money, has the public been made aware that the vaccine manufacturers have been granted immunity, and their responsibility to compensate those harmed by the vaccine has been transferred to the tax-payers?
In the context of these concerns, we propose halting mass-vaccination and opening an urgent pluralistic, critical, and scientifically-based dialogue on SARS-CoV-2 vaccination among scientists, medical doctors, international health agencies, regulatory authorities, governments, and vaccine developers. This is the only way to bridge the current gap between scientific evidence and public health policy regarding the SARS-CoV-2 vaccines. We are convinced that humanity deserves a deeper understanding of the risks than what is currently touted as the official position. An open scientific dialogue is urgent and indispensable to avoid erosion of public confidence in science and public health and to ensure that the WHO and national health authorities protect the interests of humanity during the current pandemic. Returning public health policy to evidence-based medicine, relying on a careful evaluation of the relevant scientific research, is urgent. It is imperative to follow the science.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.
Notes on Authors
1Epidemiólogos Argentinos Metadisciplinarios. República Argentina.
2Baylor University Medical Center. Dallas, Texas, USA.
3Monestir de Sant Benet de Montserrat, Montserrat, Spain
4INSERM U781 Hôpital Necker-Enfants Malades, Université Paris Descartes-Sorbonne Cité, Institut Imagine, Paris, France.
5School of Natural Sciences. Autonomous University of Querétaro, Querétaro, Mexico.
6Retired Professor of Medical Immunology. Universidad de Guadalajara, Jalisco, Mexico.
7Médicos por la Verdad Puerto Rico. Ashford Medical Center. San Juan, Puerto Rico.
8Retired Professor of Clinical Diagnostic Processes. University of Murcia, Murcia, Spain
9Urologist Hospital Comarcal de Monforte, University of Santiago de Compostela, Spain.
10Biólogos por la Verdad, Spain.
11Retired Biologist. University of Barcelona. Specialized in Microbiology. Barcelona, Spain.
12Center for Integrative Medicine MICAEL (Medicina Integrativa Centro Antroposófico Educando en Libertad). Mendoza, República Argentina.
13Médicos por la Verdad Argentina. República Argentina. ´
14Médicos por la Verdad Uruguay. República Oriental del Uruguay.
15Médicos por la Libertad Chile. República de Chile.
16Physician, orthopedic specialist. República de Chile.
17Médicos por la Verdad Perú. República del Perú.
18Médicos por la Verdad Guatemala. República de Guatemala.
19Concepto Azul S.A. Ecuador.
20Médicos por la Verdad Brasil. Brasil.
21Médicos por la Verdad Paraguay.
22Médicos por la Costa Rica.
23Médicos por la Verdad Bolivia.
24Médicos por la Verdad El Salvador.
25Correspondence: Karina Acevedo-Whitehouse, karina.acevedo.whitehouse@uaq.mx
Sources
www.gov.uk

COVID-19 confirmed deaths in England (to 31 January 2021): report

www.gov.uk www.gov.uk
Notes
  1. McCullough PA, Alexander PE, Armstrong R, et al. Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med (2020) 21:517–530. doi:10.31083/j.rcm.2020.04.264
  2. Arvin AM, Fink K, Schmid MA, et al. A perspective on potential antibody- dependent enhancement of SARS-CoV-2. Nature (2020) 484:353–363. doi:10.1038/s41586-020-2538-8
  3. Coish JM, MacNeil AJ. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Microbes Infect (2020) 22(9):405-406. doi:10.1016/j.micinf.2020.06.006
  4. Eroshenko N, Gill T, Keaveney ML, et al. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures. Nature Biotechnol (2020) 38:788–797. doi:10.1038/s41587-020-0577-1
  5. Poland GA. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Vaccine (2020) 38:4219–4220. doi:10.1016/j.vaccine.2020.04.073
  6. Shibo J. Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature (2000) 579,321. doi:10.1038/d41586-020-00751-9
  7. Munoz FA, Cramer JP, Dekker CL, et al. Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2021) https://doi.org/10.1016/j.vaccine.2021.01.055
  8. Cardozo T, Veazey R. Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease. Int J Clin Pract (2020) 28:e13795. doi: 10.1111/ijcp.13795
  9. Bolles D, Long K, Adnihothram S, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J Virol (2001) 85:12201–12215. doi:10.1128/JVI.06048-11
  10. Weingartl H, Czub M, Czub S, et al. Immunization with modified vaccinia virus Ankarabased recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. J Virol (2004) 78:12672–12676. doi:10.1128/JVI.78.22.12672-12676.2004272
  11. Tseng CT, Sbrana E, Iwata-Yoshikawa N, et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS One (2012) 7(4):e35421. doi: 10.1371/journal.pone.0035421
  12. Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol (2020) 20:339–341. doi:10.1038/s41577-020-0321-6
  13. Vennema H, de Groot RJ, Harbour DA, et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. J Virol (1990) 64:1407-1409
  14. Lambert PH, Ambrosino DM, Andersen SR, et al. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines. Vaccine (2020) 38(31):4783-4791. doi:10.1016/j.vaccine.2020.05.064
  15. de Alwis R, Chen S, Gan S, et al. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development. EbioMedicine (2020) 55:102768. doi:10.1016/j.ebiom.2020.102768
  16. Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV287 19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet (2020) 396:467–783. doi:10.1016/S0140-6736(20)31604-4
  17. Polack FP, Thomas SJ, Kitchin N. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med (2020) 383:2603–2615. doi:10.1056/NEJMoa2034577
  18. Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet (2021) 396:1979–93. doi: 10.1016/S0140-6736(20)32466-1
  19. Chu L, McPhee R, Huang W, et al. mRNA-1273 Study Group. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine (2021) S0264-410X(21)00153-5. doi:10.1016/j.vaccine.2021.02.007
  20. Liu L, Wei Q, Lin Q, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight (2019) 4(4):e123158. doi:10.1172/jci.insight.123158.
  21. Ioannidis PA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull WHO (2021) 99:19–33F. http://dx.doi.org/10.2471/BLT.20.265892
  22. Martines RB, Ritter JM, Matkovic E, et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States Emerg Infect Dis (2020) 26:2005-2015. doi:10.3201/eid2609.202095
  23. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA (2020) 323:1239-1242. doi:10.1001/jama.2020.2648
  24. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med (2020) 8:420-422 doi:10.1016/S2213-2600(20)30076-X
  25. Negro F. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? Swiss Medical Weekly (2020) 150:w20249. doi:10.4414/smw.2020.20249317
  26. Lei Y, Zhang J, Schiavon CR et al., Spike Protein Impairs Endothelial Function via Downregulation of ACE 2. Circulation Res (2021) 128:1323–1326. https://doi.org/10.1161/CIRCRESAHA.121.318902
  27. Lyons-Weiler J. Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity, J Translational Autoimmunity (2020) 3:100051. doi:10.1016/j.jtauto.2020.100051
  28. An H, Park J. Molecular Mimicry Map (3M) of SARS-CoV-2: Prediction of potentially immunopathogenic SARS-CoV-2 epitopes via a novel immunoinformatic approach. bioRxiv [Preprint]. 12 November 2020 [cited 2020 April 19] https://doi.org/10.1101/2020.11.12.344424
  29. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med (2021). doi: 10.1056/NEJMoa2104840
  30. Othman M, Labelle A, Mazzetti I et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood (2007) 109:2832–2839. doi:10.1182/blood-2006-06-032524
  31. Ortel TL. Acquired thrombotic risk factors in the critical care setting. Crit Care Med (2010) 38(2 Suppl):S43-50. doi:10.1097/CCM.0b013e3181c9ccc8
  32. Grubaugh ND, Petrone ME, Holmes EC. We shouldn’t worry when a virus mutates during disease outbreaks. Nat Microbiol (2020) 5:529–530. https://doi.org/10.1038/s41564-020-0690-4
  33. Greaney AJ, Starr TN, Gilchuk P, et al. Complete Mapping of Mutations to the SARS-CoV339 2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host Microbe (2021) 29:44–57.e9. doi:10.1016/j.chom.2020.11.007.
  34. Lauring AS, Hodcroft EB. Genetic Variants of SARS-CoV-2—What Do They Mean? JAMA (2021) 325:529–531. doi:10.1001/jama.2020.27124
  35. Zhang L, Jackson CB, Mou H, et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv [Preprint]. June 12 2020 [cited 2021 Apr 19] https://doi.org/10.1101/2020.06.12.148726
  36. Korber B, Fischer WM, Gnanakaran S et al. Sheffield COVID-19 Genomics Group. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell (2020) 182:812-827.e19. doi:10.1016/j.cell.2020.06.043
  37. Francis T. On the doctrine of original antigenic sin. Proc Am Philos Soc (1960) 104:572–578.
  38. Vibroud C, Epstein SL. First flu is forever. Science (2016) 354:706–707. doi:10.1126/science.aak9816
  39. Weisblum Y, Schmidt F, Zhang F, et al. Escape from neutralizing antibodies by SARS354 CoV-2 spike protein variants. Elife (2020) 9:e61312. doi:10.7554/eLife.61312
  40. Vanden Bossche G (March 6, 2021) https://dryburgh.com/wp-356content/...nden_Bossche_Open_Letter_WHO_March_6_2021.pdf
  41. Coish JM, MacNeil AJ. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19. Microbes Infect (2020) 22(9):405-406. doi:10.1016/j.micinf.2020.06.006
Featured image is from Children’s Health Defense
The original source of this article is enVolveCopyright © Dr. Roxana Bruno, Dr. Peter McCullough, and et al., enVolve, 2021
 

High Recorded Mortality in Countries Categorized as “Covid-19 Vaccine Champions”. The Vaccinated Suffer from Increased Risk of Mortality compared to the Non-vaccinated​

Data on Mortality in the Most Vaccinated Countries. Increased Hospitalizations of the Vaccinated​

By Gérard Delépine
Global Research, October 30, 2021

Link: https://www.globalresearch.ca/high-...e-champions-increased-hospitalization/5757173

First published on September 30, 2021
Since the beginning of the health crisis, the French government has claimed that early treatment was ineffective. It has imposed major restrictions on our freedoms, in particular on doctors’ prescriptions,[1]
It has also promised that vaccination would achieve collective immunity, the end of the crisis and a return to normal life.
But the failure for 18 months of this so-called “health strategy” based on false simulations, innumerable lies, promises never kept, as well as the propaganda and fear campaign has become unbearable.
In turn this has been followed by the extortion of consent to be vaccinated, by outright blackmail, while curtailing our freedoms to move and socialize, our right to work and engage in leisure activities.
Are the current vaccines that they want to impose on us effective?
Can they lead to a collective immunity or is it only a myth? To answer this question, we will make the current sanitary assessment of the most vaccinated countries according to the figures provided by the World Health Organization and the curves of OurWorldinData. (From Vaccine outset in December 2020 to September 15, 2021)
Record mortality in Gibraltar, champion of Astra Zeneca injections
Gibraltar (34,000 inhabitants) started vaccination in December 2020 when the health agency counted only 1040 confirmed cases and 5 deaths attributed to covid19 in this country. After a very comprehensive vaccination blitz, achieving 115% coverage (vaccination was extended to many Spanish visitors), the number of new infections increased fivefold (to 5314) and the number of deaths increased 19fold. The number of deaths increased 19-fold, reaching 97, i.e. 2853 deaths per million inhabitants, which is one of the European mortality records. But those responsible for the vaccination deny any causal link without proposing any other plausible etiology. And after a few months of calm, the epidemic resumed, confirming that 115% vaccination coverage does not protect against the disease.
image-67-1024x576.png

Malta: 84% vaccine coverage, but just as ineffective
Malta is one of the European champions of pseudo-vaccines: on this island of 500,000 inhabitants, nearly 800,000 doses have been administered, ensuring a vaccine coverage of nearly 84% with a delay of about 6 months.
But since the beginning of July 2021, the epidemic has started again and the serious (fatal) forms are increasing, forcing the authorities to recognize that vaccination does not protect the population and to impose restrictions.
image-68.png

Here again, the recurrence of the epidemic in terms of cases and mortality proves that a high rate of vaccination does not protect the population.
In Iceland, people no longer believe in herd immunity
In this small country of 360,000 inhabitants, more than 80% are primo-vaccinated and 75% have a complete vaccination cycle. But by mid-July 2021, new daily infections had risen from about 10 to about 120, before stabilizing at a rate higher than the pre-vaccination period. This sudden recurrence convinced the chief epidemiologist of the impossibility of obtaining collective immunity through vaccination. “It’s a myth,” he publicly declared.
image-69-1024x576.png

Belgium: recurrence of the disease despite vaccination
Covid-19 Vaccines Lead to New Infections and Mortality: The Evidence is Overwhelming
In Belgium, nearly 75% of the population is primo-vaccinated. And 65% of the population has a complete vaccination cycle. However, since the end of June 2021, the number of new daily infections has risen from less than 500 to nearly 2000. As RTBF acknowledges, in the face of the Delta variant, current vaccination is far from sufficient to protect the population.
Singapore abandons the hope of “Zero Covid” through vaccines
This small country is also highly vaccinated and nearly 80% of the population has received at least one dose. But since August 20, 2021, it has had to face an exponential resumption of the epidemic with an increase in cases from about ten in June to more than 150 at the end of July and 1246 cases on September 24.
image-71-1024x576.png

This uncontrolled recurrence of the disease despite vaccination has led to the abandonment of the strategy of eradicating the virus for a model of “living with the virus” by trying to treat the disease “like the flu“.
In the UK: a worrying rise in infections
The United Kingdom is the European champion of Astra Zeneca vaccination, with more than 70% of the population vaccinated for the first time, and 59% with a complete vaccination schedule. This high “vaccination” rate did not prevent an explosion of cases at the beginning of the summer, with up to 60,000 new cases per day by mid-July.
Faced with this significant resumption of the epidemic despite vaccination, Andrew Pollard, representative of the Oxford Vaccine Group, acknowledged before Parliament: “collective immunity through vaccination is a myth“.
image-72-1024x576.png

This resumption of infections has been accompanied by a resumption of hospitalizations, severe cases and deaths. According to the official report of August,[2] deaths were more frequent among fully vaccinated patients (679) than among non-vaccinated patients (390), thus cruelly denying the hopes of a protective effect of the vaccine on mortality.
After the last sanitary restrictions were lifted, the epidemic decreased to a level of less than 30,000 cases per day, whereas at the beginning of July, simulations by covid specialists were predicting up to 100,000 new cases per day if the sanitary measures were removed.
Israel: obvious post-vaccination disaster denied by officials
Israel, champion of the Pfizer injection, once everywhere cited as an example of effectiveness, is now being harshly reminded of reality and is now the model of vaccine failure.
70% of the population is primo-vaccinated, and nearly 90% of those at risk have a complete vaccination cycle. But the epidemic has rebounded stronger than ever since the end of June, and more than 11,000 new cases were recorded in 1 day (September 14, 2021) surpassing the peaks seen in January 2021 during the outbreak following the first Pfizer injections by nearly 50%.
image-73-1024x576.png

This resumption of the epidemic, despite the Pfizer injections, is accompanied by an increase in hospitalizations where the vaccinated represent the majority of those hospitalized.
image-74-1024x576.png
Vaccination does not protect against severe forms of the disease or against death.
image-75.png

End of July: 71% of the 118 seriously ill Israelis (serious, critical) were fully vaccinated!
This proportion of seriously ill people vaccinated is much higher than the proportion of fully vaccinated people: 61%. To claim that the vaccine protects against serious forms of the disease, as the Israeli Minister of Health imprudently declared, is a mistake (or disinformation?).
In order not to acknowledge its mistakes, the Israeli government remains in denial of this obvious failure and continues to propose only vaccination as a solution. How many more deaths will it take before it follows the example of India or Japan and finally adopts early treatment?
Conclusions
The current pseudo vaccines are not effective enough. They do not prevent the recurrence of the epidemic, nor hospitalizations, nor severe forms, nor death. In Israel and Great Britain, which specify the vaccination status of the victims, the vaccinated suffer from an increased risk of mortality compared to the non-vaccinated.
The pursuit of a vaccine-only policy leads to a deadly impasse, whereas countries that officially advise early treatment (India) or allow their doctors to prescribe it (Japan, Korea) fare much better.
image-76-1024x576.png

What are our health authorities waiting for to stop believing in false simulations carried out by epidemiologists who are too closely linked to vaccine companies, to look at the proven facts and to interrupt their deceptive and deleterious pro-vaccination campaign and recommend early treatment?
The continuation of the ban on early treatment by treating physicians leads to a loss of chances for many patients and directly engages the responsibility of the government and particularly the Minister of Health.
Dr Gérard Delépine is an oncologist and statistician
Translated from French by Global Research.
Notes
[1] For the first time in 2500 years…
[2] SARS-CoV-2 variants of concern and variants under investigation in England Technical briefing 21
Published August 2021 Public Health England Gateway number : GOV 9374 20 August 2021
The original source of this article is nouveau-monde.ca, published on our French language web site mondialisation.ca
Copyright © Dr. Gérard Delépine, nouveau-monde.ca, 2021
The original source of this article is Global ResearchCopyright © Gérard Delépine, Global Research, 2021
 
You must log in or register to reply here.
Back
Top